This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
milla1cf Fri, 02/02/2024 - 17:18 February 2, 2024 — GE HealthCare (Nasdaq: GEHC) announces the latest innovation in electrophysiology (EP), the Prucka 3 with CardioLab EP Recording system, to help clinicians in the diagnosis and treatment of cardiac arrhythmias. million people in the United States by 2050 and 17.9
While AF arises in old age, the combined effects of widespread structural, electrophysiological and autonomic remodeling make it difficult to discern the exact mechanisms of arrhythmia generation. Investigation prior to overt structural remodeling may therefore be required.
What Clinics Can Do to Protect the Diagnosis and Treatment of Cardiac Arrhythmias Scope of Reimbursement Cuts The release of the annual Proposed Medicare Physician Fee Schedule is an event that business leaders and caregivers in healthcare anxiously anticipate.
Evidence suggests a reduced incidence of ventricular and atrial arrhythmias in patients with dapagliflozin or empagliflozin treatment. It is unclear to what extent the reduced arrhythmia burden is due to direct effects of the SGLT2 inhibitors or is solely a marker of improved cardiac function.
Electroanatomic mapping (EM) has revolutionized the understanding and ablation of complex arrhythmias by providing simultaneous representation of electrogram timing, location, and voltage in both space and time.
BackgroundIschemic cardiomyopathy (ICM) is the end stage of ischemic heart disease, in which ventricular remodeling contributes to a fatal ventricular arrhythmia, worsens heart function and unfavorable outcomes, and is related to persistent chronic inflammation. Journal of the American Heart Association, Ahead of Print.
Establishing the precise mechanism of cardiac arrhythmias in the electrophysiology laboratory is one of the main requisites for a successful and safe ablation.
Personalized computational models ("digital twins") of cardiac electrophysiology (EP) based on clinical imaging have shown potential utility in arrhythmia prognostics and treatment planning.
We sought to evaluate the electrophysiological characteristics and durability of PFA lesions, encompassing not only PVI but also left atrium (LA) posterior lines and left posterolateral mitral isthmus lines in a series of consecutive patients with recurrent atrial tachyarrhythmias after an index PFA procedure using a pentaspline catheter.
Promising as a treatment option for life-threatening ventricular arrhythmias, cardiac stereotactic body radiotherapy (cSBRT) has demonstrated early antiarrhythmic effects within days of treatment. The mechanisms underlying the immediate and short-term antiarrhythmic effects are poorly understood.
Notwithstanding many insightful observations, the electrocardiogram (ECG) arguably ignited the big bang in our understanding of cardiac arrhythmias. The development of electrophysiology (EP) studies through intravascular catheters provided the leap to verifying mechanisms, setting the stage for interventions.
With the unveiling of the Genesis System, Baptist Health Lexington has become the first in Kentucky, and one of the first in the world, to provide the latest advancement in robotic technology to treat cardiac arrhythmias. “We In 2006, Lewis realized something was not right with his heart during one of his regular outdoor runs.
The spatial ventricular gradient (SVG), a vectorcardiographic measure of electrical heterogeneity, has been associated with arrhythmic events over long-term follow-up, but its relationship with short-term inducibility of ventricular arrhythmias (VAs) is unclear.
“As electrophysiologists, our primary goal is to improve the lives of our patients,” said Dr. Mario Volpicelli , Head of the Electrophysiology Unit of the hospital. Robotic Magnetic Navigation introduces the benefits of robotic precision and safety to cardiac ablation, a common minimally invasive procedure to treat arrhythmias.
However, the incidence of ventricular arrhythmias (VAs) is high in this population, both in the acute and delayed phases after implantation. Abstract Left ventricular assist device (LVAD) implantation is an established treatment for patients with advanced heart failure refractory to medical therapy.
The field of invasive cardiac electrophysiology (EP) has witnessed extraordinary advancements over the past 57 years, beginning with the foundational recording of the His bundle electrogram in 1969 by Anthony Damato, MD.
In electrophysiology, innovation is king, but it is often incremental, and it almost always lacks rationale, comprehensive clinical documentation and relevance for hospitals that try to balance the increasing costs of new technology with increasing demand and reimbursement that just can’t keep pace.
Circulation: Arrhythmia and Electrophysiology, Ahead of Print. Three months after the index procedure, patients underwent a repeat electrophysiology study to identify pulmonary vein reconnections. Forty patients underwent a repeat electrophysiology study. or acute reconnection (4% versus 14%;P=0.3)
There is limited data regarding safety, electrophysiologic characteristics and arrhythmia substrate during ventricular tachycardia (VT) ablation in patients with prior aortic valve replacement (AVR).
Ventricular tachycardia (VT) ablation in structural heart disease improves arrhythmia free survival. Procedural factors that influence these outcomes are not well described.
Circulation: Arrhythmia and Electrophysiology, Ahead of Print. BACKGROUND:The strongest genetic risk factors for atrial fibrillation (AF) are DNA variants on chromosome 4q25 near the transcription factor genePITX2.
The findings, led by investigators in the Smidt Heart Institute at Cedars-Sinai, published in Circulation: Arrhythmia and Electrophysiology. Patients who present with persistent atrial fibrillation at diagnosis are more likely to have certain risk factors as compared with patients with occasional atrial fibrillation (AFib).
Studies have shown that mutations in the RYR2 gene, which encodes the RyR2 protein, are linked to several cardiac arrhythmias, including catecholaminergic polymorphic ventricular tachycardia (CPVT), long QT syndrome (LQTS), calcium release deficiency syndrome (CRDS), and atrial fibrillation (AF).
Adult patients with repaired Tetralogy of Fallot (rTOF) have a high incidence of ventricular arrhythmias from an early age due to slowly conducting anatomic isthmuses (SCAI) between valves and scars or patches from the repair.
Computational modeling of the heart has become an important research tool in cardiac electrophysiology and arrhythmias with recent advances in real-world applications. Artificial intelligence (AI) is revolutionizing cardiac arrhythmia management by aiding detection, predicting risk, and contributing to clinical decision-making.
BackgroundHuman pluripotent stem cell-derived cardiomyocytes (hPSC-CMs) show tremendous promise for cardiac regeneration following myocardial infarction (MI), but their transplantation gives rise to transient ventricular tachycardia (VT) in large-animal MI models, representing a major hurdle to translation.
Although the electrcardiographic and electrophysiological properties of ventricular arrhythmias (VA) from the vicinity of lateral tricuspid annulus (TA) have been reported in previous studies, their precise site of origin have not been addressed.
Circulation: Arrhythmia and Electrophysiology, Ahead of Print. BACKGROUND:Epicardial radiofrequency catheter ablation (RFCA) of idiopathic ventricular arrhythmias (VAs) originating from the left ventricular summit (LVS) is challenging because of the anatomic barriers.
Atrial fibrillation is the most common type of arrhythmia, and by 2050, up to 16 million Americans are projected to have AF 1. Antonius Hospital, Netherlands , professor of electrophysiology, Amsterdam UMC , and lead investigator of the FARADISE registry. “We director of electrophysiology, Mount Sinai Fuster Heart Hospital , New York.
In this respect, the role of electrophysiology study (EPS) has been subject of debate. Risk stratification in Brugada syndrome (BrS) remains controversial. In some centers, it is common practice to use an implantable loop recorder (ILR) after a negative EPS to help risk stratification.
Circulation: Arrhythmia and Electrophysiology, Ahead of Print. BACKGROUND:Population genomic screening for desmosome variants associated with arrhythmogenic right ventricular cardiomyopathy (ARVC) may facilitate early disease detection and protective intervention.
Abstract The limited literature and increasing interest in studies on cardiac electrophysiology, explicitly focusing on cardiac ion channelopathies and sudden cardiac death in diverse populations, has prompted a comprehensive examination of existing research.
The most common arrhythmia, atrial fibrillation , will affect approximately 12.1 Leadless pacemakers are considered the future in the treatment of heart arrhythmias and have allowed many patients to live their lives with no visible evidence of a pacemaker or heart device," said Birgersdotter-Green.
Volta Medical has announced it has entered into a Joint Development Agreement with GE Healthcare to enhance arrhythmia procedures with artificial intelligence (AI)-driven electrophysiology technologies. Our mission to combat complex heart rhythm diseases relies on optimizing interoperability.
Myocardial calcium (Ca2+) signaling plays a crucial role in contractile function and membrane electrophysiology. An abnormal myocardial Ca2+ transient is linked to heart failure and ventricular arrhythmias.
Diabetes mellitus induces adverse structural, electrophysiological, and autonomic cardiac remodeling which can increase one’s risk of ventricular arrhythmias and SCD. Diabetes mellitus (DM) confers an increased risk of sudden cardiac death (SCD) independent of its associated cardiovascular comorbidities.
Among the most serious manifestations associated with HF is arrhythmia due to the electrophysiological changes within the cardiomyocyte. Among these electrophysiological changes, disruptions in sodium and potassium currents’ function and trafficking, as well as calcium handling, all of which impact arrhythmia in HF.
Massie Block -Ref 1) But, if there is something unusual in the clinical history, be ready to investigate until the arrhythmia, or at least the anxiety disappears. Clinical and electrophysiologic findings in patients with paroxysmal slowing of the sinus rate and apparent Mobitz type II atrioventricular block. Reference 1. PMID: 668079.
We organize all of the trending information in your field so you don't have to. Join thousands of users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content